Direct C3-alkenylation of pyridin-4(1H)-one via oxidative Heck coupling

Tetrahedron

Volumn 69, Issue 3, 2013, Pages 1115-1119

  Zhang, Guangling ^a   Li, Ziyuan ^a   Huang, Yue ^a   Xu, Jinyi ^a   Wu, Xiaoming ^a   Yao, Hequan ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Alkenylation; C H activation; Catalysis; Oxidative Heck coupling; Pyridin 4(1H) one

Indexed keywords

PALLADIUM; PIVALIC ACID; PYRIDIN 4(1H) ONE DERIVATIVE; PYRIDONE DERIVATIVE; UNCLASSIFIED DRUG;

ALKENYLATION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CHEMICAL REACTION; DRUG SCREENING; DRUG SYNTHESIS; HECK REACTION; HYDROGEN BOND; NUCLEAR OVERHAUSER EFFECT; OXIDATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS;

EID: 84871638849     PISSN: 00404020     EISSN: 14645416     Source Type: Journal    
DOI: 10.1016/j.tet.2012.11.061     Document Type: Article

References (52)

1. For recent reviews and examples on transition metal catalyzed C-C bond formation, see: L. Ackermann, R. Vicente, and A.R. Kapdi Angew. Chem., Int. Ed. 48 2009 9792
2. X. Chen, K.M. Engle, D.-H. Wang, and J.-Q. Yu Angew. Chem., Int. Ed. 48 2009 5094
3. D. Alberico, M.E. Scott, and M. Lautens Chem. Rev. 107 2007 174
4. T.W. Lyons, and M.S. Sanford Chem. Rev. 110 2010 1147
5. L. McMurray, F. O'Hara, and M.J. Gaunt Chem. Soc. Rev. 40 2011 1885
6. R.F. Heck B.M. Trost, I. Fleming, Comprehensive Organic Synthesis Vol. 4 1991 Pergamon Oxford
7. N. Miyaura, and A. Suzuki Chem. Rev. 95 1995 2457
8. T.Y. Luh, M.K. Leung, and K.T. Wong Chem. Rev. 100 2000 3187
9. B.M. Trost, and M.L. Crawley Chem. Rev. 103 2003 2921
10. K.C. Nicolaou, P.G. Bulger, and D. Sarlah Angew. Chem., Int. Ed. 44 2005 4442
11. D.S. Surry, and S.L. Buchwald Angew. Chem., Int. Ed. 47 2008 6338
12. L.-M. Xu, B.-J. Li, Z. Yang, and Z.-J. Shi Chem. Soc. Rev. 39 2010 712
13. For reviews and examples on palladium-catalyzed double C-H activation, see: C.S. Yeung, and V.M. Dong Chem. Rev. 111 2011 1215
14. S.L. You, and J.B. Xia Top. Curr. Chem. 292 2010 165
15. J.A. Ashenhurst Chem. Soc. Rev. 39 2010 540
16. G.P. McGlacken, and L.M. Bateman Chem. Soc. Rev. 38 2009 2447
17. D.A. Colby, R.G. Bergman, and J.A. Ellman Chem. Rev. 110 2010 624
18. Y. Su, and N. Jiao Curr. Org. Chem. 15 2011 3362
19. S.Y. Kyung, H.Y. Cheol, and W.J. Kyung J. Am. Chem. Soc. 128 2006 16384
20. J.D. Crowley, K.D. Hänni, A.-L. Lee, and D.A. Leigh J. Am. Chem. Soc. 129 2007 12092
21. D.-C. Xiong, L.-H. Zhang, and X.-S. Ye Org. Lett. 11 2009 1709
22. Y. Su, and N. Jiao Org. Lett. 11 2009 2980
23. D. Pan, M. Yu, W. Chen, and N. Jiao Chem. - Asian J. 5 2010 1090
24. For selected examples of bioactive alkenylated heterocycles, see: (a) Q. Xu, L. Huang, J. Liu, L. Ma, T. Chen, J. Chen, F. Peng, D. Cao, Z. Yang, N. Qiu, J. Qiu, G. Wang, X. Liang, A. Peng, M. Xiang, Y. Wei, and L. Chen Eur. J. Med. Chem. 52 2012 70
25. M. Hasmann, and I. Schemainda Cancer Res. 63 2003 7436
26. Caroff, E.; Hilpert, K.; Hubler, F.; Lehmann, D.; Meyer, E.; Renneberg, D. WO 2010/122504A1, 2010.
27. Baell, J. B.; Bui, C. T.; Colman, P.; Dubley, D. A.; Fairbrother, W. J.; Flygare, J. A.; Lassene, G. L.; Ndubaku, C.; Nicolakopoulos, G.; Rye, C. S.; Sleebs, B. E.; Smith, B. J.; Watson, K. G.; Elmore, S. W.; Petros, A. M.; Souers, A. J. WO 2010/080478A1, 2010.
28. Adamczewski, M.; Arnold, C.; Becker, A.; Carles, L.; Dahmen, P.; Dunkel, R.; Franken, E.; Gorgens, U.; Grosjean-Cournoyer, M.; Helmke, H.; Hillebrand, S.; Hiroyuki, H.; Kluth, J.; Knobloch, T.; Losel, P.; Nennstiel, D.; Rieck, H.; Rama, R.; Suelmann, R.; Voerste, A.; Wachendorff-Neumann, U. WO 2010/012793A1, 2010.
29. Martin, S.; Bergstrom, C. P.; Gentles, R. G.; Yeung, K. S. WO 2009/029384A2, 2009.
30. For selected examples of pyridin-4(1H)-one based bioactive compounds, see: (a) K. Barral, J. Balzarini, J. Neyts, E. De Clercq, R.C. Hider, and M. Camplo J. Med. Chem. 49 2006 43
31. G. Öztürk, D.D. Erol, M.D. Aytemir, and T. Uzbay Eur. J. Med. Chem. 37 2002 829
32. D. Bebbington, N.J.T. Monck, S. Gaur, A.M. Palmer, K. Benwell, V. Harvey, C.S. Malcolm, and R.H.P. Porter J. Med. Chem. 43 2000 2779
33. G. Liu, F.W. Bruenger, S.C. Miller, and A.M. Arif Bioorg. Med. Chem. Lett. 8 1998 3077
34. J. Matulic-Adamic, C. Gonzalez, N. Usman, and L. Beigelman Bioorg. Med. Chem. Lett. 6 1996 373
35. For selected examples of bioactive compounds bearing 2-hydroxymethyl-5- hydroxyl pyridin-4(1H)-one scaffold, see: (a) L.S. Dehkordi, Z.D. Liu, and R.C. Hider Eur. J. Med. Chem. 43 2008 1035
36. M.C. Pirrung, L. Deng, B. Lin, and N.J. Webster ChemBioChem 9 2008 360
37. Y.-L. Chen, P.-H. Chen, C.-H. Chung, K.-C. Li, H.-Y. Jeng, and C.-C. Tzeng Helv. Chim. Acta 86 2003 778
38. Shin, K. J.; Roh, E. J.; Chung, M. K.; Cha, H. J.; Seo, S. H. WO 2011/014008A2, 2011.
39. K.N. Maloney, J.B. MacMillan, C.A. Kauffman, P.R. Jensen, A.G. DiPasquale, A.L. Rheingold, and W. Fenical Org. Lett. 11 2009 5422
40. M. Li, L. Li, and H. Ge Adv. Synth. Catal. 352 2010 2445
41. H. Ge, M.J. Niphakis, and G.I. Georg J. Am. Chem. Soc. 130 2008 3708
42. D. Kim, and S. Hong Org. Lett. 13 2011 4466
43. For our previous works on N-containing heteroarenes, see: (a) Z. Li, L. Ma, J. Xu, L. Kong, X. Wu, and H. Yao Chem. Commun. 2012 3763
44. L. Zhao, Z. Li, L. Chang, J. Xu, H. Yao, and X. Wu Org. Lett. 14 2012 2066
45. Z. Li, L. Ma, C. Tang, J. Xu, X. Wu, and H. Yao Tetrahedron Lett. 52 2011 5643
46. Z. Li, Y. Wang, Y. Huang, C. Tang, J. Xu, X. Wu, and H. Yao Tetrahedron 67 2011 5550
47. Y. Wang, Z. Li, Y. Huang, C. Tang, X. Wu, J. Xu, and H. Yao Tetrahedron 67 2011 7406
48. Y. Huang, L. Ni, H. Gan, Y. He, J. Xu, X. Wu, and H. Yao Tetrahedron 67 2011 2066
49. Y. Huang, H. Gan, S. Li, J. Xu, X. Wu, and H. Yao Tetrahedron Lett. 51 2010 1751
50. L. Ackermann Chem. Rev. 111 2011 1315
51. D. Lapointe, and K. Fagnou Chem. Lett. 39 2010 1118
52. J. Roger, A.L. Gottumukkala, and H. Doucet ChemCatChem 2 2010 20